NCT06409884View on ClinicalTrials.gov

Diagnosing Drug Allergy: the T is the Key

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

May 21, 2024

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions
Amoxicillin Allergy
Interventions
DEVICE

T-cell activation test using intracellular markers

A blood sample will be taken which is needed for the T-cell activation test (TAT). The TAT will than be performed by trained laboratory personnel.

Trial Locations (1)

2650

RECRUITING

Antwerp University Hospital, Edegem

All Listed Sponsors
collaborator

AZ Jan Palfijn Gent

OTHER

collaborator

Universiteit Antwerpen

OTHER

lead

University Hospital, Antwerp

OTHER